• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Halitosis Treatment Market

    ID: MRFR/Pharma/2493-CR
    153 Pages
    Kinjoll Dey
    August 2017

    Halitosis Treatment Market Research Report Information By Indication (Respiratory, Liver, Kidney, Gastrointestinal, Systemic, and Others), By Diagnostic Tests (Halimeter, Gas Chromatography, BANA Test, Β-Galactosidase Activity Assay, and Others), By Drug Treatment (Antacids, Antiseptics, Ranitidine, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Halitosis Treatment Market Infographic
    Purchase Options

    Halitosis Treatment Market Summary

    The Global Halitosis Treatment Market is projected to grow significantly from 4.89 USD Billion in 2024 to 14.70 USD Billion by 2035.

    Key Market Trends & Highlights

    Halitosis Treatment Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.54% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 14.7 USD Billion, indicating robust growth potential.
    • in 2024, the market is valued at 4.89 USD Billion, reflecting the current demand for halitosis treatments.
    • Growing adoption of innovative oral hygiene products due to increasing awareness of oral health is a major market driver.

    Market Size & Forecast

    2024 Market Size 4.89 (USD Billion)
    2035 Market Size 14.70 (USD Billion)
    CAGR (2025-2035) 10.52%

    Major Players

    Colgate-Palmolive Company, All USA Partners LLC, Dr. Harold Katz, LLC, Rowpar Pharmaceuticals, Inc., Abbott, Listerine, AstraZeneca

    Halitosis Treatment Market Trends

    Growing treatment is driving the market growth

    Market CAGR for halitosis treatment is being driven by the rising treatment. Further factors driving the market's expansion include the increased incidence of periodontal disorders, rising alcohol and tobacco usage, tonsillitis, and inflammation of the nose, throat, and sinuses. Halitosis is believed to be the third most prevalent cause for seeing a dentist, after periodontal disease and dental caries, according to a study titled "The Prevalence and Determinant Factors of Oral Halitosis in Northwest Ethiopia: A Cross-Sectional Study" released by Dovepress in 2021. Between 22% and 50% of individuals worldwide reported having halitosis.

    As a result, a key element anticipated to influence halitosis diagnosis and therapy shortly is the rising incidence of the condition worldwide.

    Additionally, gum (periodontal) disease, closely related to halitosis, may show warning signs such as chronic foul breath or an unpleasant taste in the mouth. The prevalence of total periodontitis and stage III/IV periodontitis was 85.4% and 48.5%, respectively, according to a study titled "Periodontal Disease Prevalence, Extent, and Risk Associations in Untreated Individuals" that was released in January 2022 by the AAP and the EFP. 78.4% and 31.1%, respectively, of people had moderate-to-severe periodontitis, according to the CDC/AAP. Therefore, it is anticipated that the rising frequency of periodontal disorders will propel market expansion during the study period.

    Halitosis is a widespread problem worldwide where severe instances only affect 5% of the population, but intermediate cases are common. The market is growing as the number of persons with halitosis increases and public knowledge of the condition and its treatment increases. In the US, almost 80 million people spend more than USD 10.75 billion yearly on dental care items. Thus, driving the Halitosis Treatment market revenue.

    The increasing awareness of oral hygiene and the rising prevalence of halitosis among the global population suggest a growing demand for effective treatment options in the halitosis treatment market.

    Centers for Disease Control and Prevention (CDC)

    Halitosis Treatment Market Drivers

    Market Growth Projections

    Growth of the Dental Care Sector

    The expansion of the dental care sector is significantly influencing the Global Halitosis Treatment Market Industry. As more individuals prioritize regular dental check-ups and preventive care, the likelihood of halitosis being diagnosed and treated increases. Dental professionals are increasingly incorporating discussions about bad breath into routine consultations, thereby raising awareness among patients. This proactive approach not only aids in early detection but also encourages the use of specialized products designed to combat halitosis. The synergy between dental care and halitosis treatment is likely to foster market growth, as consumers become more engaged in their oral health management.

    Innovations in Treatment Options

    Innovative advancements in treatment options for halitosis are propelling the Global Halitosis Treatment Market Industry forward. The introduction of new formulations, such as mouthwashes, sprays, and lozenges specifically designed to combat bad breath, is attracting consumer interest. For instance, products containing active ingredients like zinc compounds and essential oils are gaining popularity due to their effectiveness in neutralizing odor-causing bacteria. Furthermore, the development of personalized oral care solutions, which cater to individual needs, is likely to enhance consumer satisfaction and loyalty. This trend suggests a robust growth trajectory for the market, with a projected CAGR of 10.54% from 2025 to 2035.

    Rising Awareness of Oral Hygiene

    The increasing awareness regarding oral hygiene and its direct correlation with halitosis is a significant driver for the Global Halitosis Treatment Market Industry. Educational campaigns by dental associations and health organizations emphasize the importance of maintaining oral health, thereby encouraging consumers to seek effective treatments for bad breath. As individuals become more informed about the causes of halitosis, including poor dental care and certain medical conditions, the demand for specialized products and treatments is likely to rise. This heightened awareness is expected to contribute to the market's growth, with projections indicating a market value of 4.89 USD Billion in 2024.

    Consumer Demand for Natural Products

    The growing consumer preference for natural and organic products is shaping the Global Halitosis Treatment Market Industry. Many individuals are becoming more health-conscious and are seeking treatments that align with their values regarding sustainability and natural ingredients. This trend is evident in the rising popularity of mouthwashes and sprays made from herbal extracts and essential oils, which are perceived as safer alternatives to synthetic products. As manufacturers respond to this demand by developing natural formulations, the market is likely to witness an increase in product offerings. This shift towards natural solutions may further enhance the overall growth of the halitosis treatment market.

    Increasing Prevalence of Oral Diseases

    The rising prevalence of oral diseases, such as periodontal disease and dry mouth, is a crucial factor driving the Global Halitosis Treatment Market Industry. These conditions often lead to halitosis, prompting individuals to seek effective treatments. According to health statistics, a significant portion of the global population experiences some form of oral disease, which can exacerbate bad breath. As healthcare providers focus on preventive care and treatment options, the demand for halitosis solutions is expected to surge. This trend is indicative of a broader public health concern, with the market anticipated to reach 14.7 USD Billion by 2035, reflecting the urgent need for effective interventions.

    Market Segment Insights

    Halitosis Treatment Indication Insights

    Based on indication, the Halitosis Treatment market segmentation includes respiratory, liver, kidney,

    gastrointestinal,

    systemic, and others. The liver segment dominated the market, accounting for 35% of market revenue. Trimethylamine is more prevalent in cirrhotic patients, which leads to bad breath. One of the odd symptoms of fatty liver disease is "breath of the dead." The Fetor hepaticus, often known as the breath of the dead, is a lingering odor that differs from typical breath. Hepatitis and liver failure are intimately connected to fetor hepaticus. 

    Organ-related bad breath is typically caused by a sickness or food that interacts with blood levels and generates an odor. Since liver illnesses and bad breath are frequently linked, the rise in liver diseases is anticipated to accelerate the segment's growth throughout the projected period.

    Halitosis Treatment Diagnostic Tests Insights

    Based on diagnostic tests, the Halitosis Treatment market segmentation includes an altimeter, gas

    chromatography

    , BANA test, and Β-galactosidase activity assay. The BANA test segment dominated the market. The BANA test assesses the proteolytic activity of certain oral anaerobes that contribute to oral malodor. It refers to the enzymatic breakdown of [N-benzoyl-dL-arginine-2-napthylamide]. Treponema denticola, Prophyromona gingivitis, and Bacteroides forsythias (Red complex) are a few bacteria that create waste products that are highly odiferous and, as a result, contribute to foul breath. The N-benzoyl enzyme is destroyed when a patient's saliva sample containing these bacteria is added to the BANA testing chemical. The test substance changes color due to this biodegradation, indicating a successful response.

    Halitosis Treatment Drug Treatment Insights

    The Halitosis Treatment market segmentation, based on Drug Treatment, includes antacids, antiseptics, ranitidine, and others. The antacids generated the most income. Antacids are frequently used since they are affordable and help to reduce the discomfort, irritation, edema, and inflammation brought on by heartburn. Additionally, several product advancements, such as creating powerful and safe raft-forming antacids that offer improved efficacy and a longer duration of action, are boosting the market's expansion. The market is expected to develop due to the increasing use of chewable tablets in various flavors that are convenient to store, deliver the right dosage, and enhance patient adherence.

    Figure 1: Halitosis Treatment Market, by Drug Treatment, 2022 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about Halitosis Treatment Market Research Report- Forecast till 2032

    Regional Insights

    By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Halitosis Treatment market area will dominate this market due to an increase in periodontal disorders, a rise in halitosis prevalence, and increased general knowledge of the condition and its treatment options.

    Further, the major countries studied in the market report are The US, Canada, the UK, Italy, Spain, China, Japan, India, German, France, Australia, South Korea, and Brazil.

    Figure 2: HALITOSIS TREATMENT MARKET SHARE BY REGION 2022 (USD Billion)

     

    HALITOSIS TREATMENT MARKET SHARE BY REGION 2022 Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe has the second-largest market share for Halitosis Treatment. Due to rising oral hygiene awareness among people and rising diagnostic and therapeutic options for treating foul breath in several regional nations, the increasing prevalence of chronic illnesses like diabetes, respiratory conditions, and renal or liver failure with the growing population. Growing older adults with various conditions also contribute to the market's expansion. Furthermore, the German Halitosis Treatment market dominated, while the UK Halitosis Treatment market grew fastest in Europe.

    From 2023 to 2032, the Asia-Pacific Halitosis Treatment Market will develop at the quickest CAGR. A rise in knowledge about halitosis and the treatments available to cure it. Additionally, rising consumer desire for novel dental care products impacts market expansion. The region's residents make significant financial investments in healthcare, particularly dental care. Future growth of the market is predicted. Furthermore, China's Halitosis Treatment market had the highest market share, whereas India's Halitosis Treatment market was the Asia-Pacific region's fastest growing.

    Key Players and Competitive Insights

    Leading market companies are extensively spending R&D on increasing their product lines, which will help the Halitosis Treatment market grow even more. Important market developments include new product releases, acquisitions and mergers, contractual agreements, greater investments, and collaboration with other organizations. The Halitosis Treatment industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.

    Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Halitosis Treatment industry to serve clients and expand the market sector. The Halitosis Treatment industry has provided some of the most important benefits recently. Church & Dwight., Colgate-Palmolive, and other major companies in the Halitosis Treatment market are aiming to enhance market demand by investing in research and development activities

    American consumer goods corporation Colgate-Palmolive has its main office on Park Avenue in Midtown Manhattan, New York City. Production, distribution, and provision of domestic, health, personal care, and veterinary items are the company's areas of expertise. The biggest manufacturer of soap and detergent in the world, Procter & Gamble (P&G), has long been a rival of Colgate-Palmolive. Following World War II, P&G launched their Tide laundry detergent, which attracted thousands of customers away from Colgate's soaps. When P&G introduced fluoride to their toothpaste, Colgate lost its top spot in the market (Colgate has subsequently reclaimed the top sales spot).

    In May 2021, In the United States, Colgate's Hello Products debuted fresh, natural, and eco-friendly oral care items like a reusable toothbrush, floss flavored with peppermint oil and coconut oil, tablets that freshen breath, and mouthwashes.

    The market leader in home and personal care goods is Church & Dwight. ARM & HAMMER, Batiste, OxiClean, Trojan, XTRA, Nair, First Response, Spinbrush, Orajel, vita fusion, Li'l Critters, Water Pik, FLAWLESS, Zicam, and TheraBreath are just a few of our internationally recognized brands. They were established in 1846, operate internationally, and are included in the S&P 500. At Church & Dwight, they fuel people's daily lives by offering high-quality, cost-effective consumer goods. Where impact meets ambition is here. They are proud to be experts in our fields. Their team of highly skilled individuals innovates and concentrates on innovative methods.

    In November 2021, Church & Dwight Co., Inc. signed a legally binding contract to buy the TheraBreath name. TheraBreath is the second most popular brand of alcohol-free mouthwash in the US. Therefore, these advancements will probably help the market in North America flourish.

    Key Companies in the Halitosis Treatment Market market include

    Industry Developments

    • Q2 2024: TheraBreath Launches New Oral Rinse Targeting Halitosis TheraBreath announced the launch of a new oral rinse specifically formulated to target halitosis, expanding its product portfolio in the oral care market.
    • Q2 2024: GSK Introduces Sensodyne Fresh Breath Toothpaste for Halitosis Relief GlaxoSmithKline launched Sensodyne Fresh Breath Toothpaste, designed to address halitosis while providing sensitivity relief, marking a new addition to its oral health product line.
    • Q3 2024: Oral Science Announces Partnership with Dental Clinics for Halitosis Treatment Program Oral Science entered into a partnership with a network of dental clinics to implement a specialized halitosis treatment program using its proprietary products.
    • Q3 2024: Colgate-Palmolive Expands Manufacturing Facility for Halitosis Treatment Products Colgate-Palmolive announced the expansion of its manufacturing facility in New Jersey to increase production capacity for its halitosis treatment product line.
    • Q4 2024: FDA Approves New Prescription Mouthwash for Chronic Halitosis The U.S. FDA approved a new prescription mouthwash developed for chronic halitosis, marking a regulatory milestone for advanced oral care therapeutics.
    • Q4 2024: Johnson & Johnson Acquires BreathRx Brand to Strengthen Halitosis Portfolio Johnson & Johnson completed the acquisition of the BreathRx brand, enhancing its portfolio of products targeting halitosis and oral malodor.
    • Q1 2025: LISTERINE Launches Advanced Formula for Bad Breath in Asia-Pacific LISTERINE introduced an advanced mouthwash formula targeting bad breath in the Asia-Pacific region, aiming to capture growing demand for halitosis solutions.
    • Q1 2025: Oral Care Startup BreathWell Raises $15M Series A to Develop Halitosis Diagnostic Device BreathWell, a health tech startup, secured $15 million in Series A funding to accelerate development of its non-invasive halitosis diagnostic device.
    • Q2 2025: Procter & Gamble Announces Strategic Partnership with Dental Chain for Halitosis Education Procter & Gamble formed a strategic partnership with a major dental chain to launch a halitosis education and treatment initiative across multiple clinics.
    • Q2 2025: FreshBreath Technologies Files for IPO to Fund Halitosis Treatment Product Expansion FreshBreath Technologies filed for an initial public offering, aiming to raise capital for expanding its halitosis treatment product line and global distribution.
    • Q3 2025: Dentek Unveils New Tongue Cleaner for Halitosis Prevention Dentek launched a new tongue cleaner designed to help prevent halitosis, broadening its oral hygiene product offerings.
    • Q3 2025: Novartis Receives European Approval for Halitosis Treatment Tablet Novartis received regulatory approval in Europe for its new tablet indicated for the treatment of halitosis, expanding its presence in the oral care therapeutics market.

    Future Outlook

    Halitosis Treatment Market Future Outlook

    The Halitosis Treatment Market is projected to grow at a 10.52% CAGR from 2025 to 2035, driven by increasing awareness of oral hygiene, technological advancements, and rising demand for effective treatments.

    New opportunities lie in:

    • Develop innovative, natural-based halitosis treatments targeting health-conscious consumers.
    • Leverage telehealth platforms for remote consultations and personalized treatment plans.
    • Expand distribution channels through e-commerce to reach a broader audience globally.

    By 2035, the Halitosis Treatment Market is expected to be robust, reflecting significant advancements and consumer engagement.

    Market Segmentation

    Halitosis Treatment Regional Outlook

    North America
    • US
    • Canada
    Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    Rest of the World
    • Middle East
    • Africa
    • Latin America

    Halitosis Treatment Indication Outlook

    • Respiratory
    • Liver
    • Kidney
    • Gastrointestinal
    • Systemic
    • Others

    Halitosis Treatment Diagnostic Tests Outlook

    • Halimeter
    • Gas Chromatography
    • BANA Test
    • Β-Galactosidase Activity Assay
    • Others

    Halitosis Treatment Drug Treatment Outlook

    • Antacids
    • Antiseptics
    • Ranitidine
    • Others

    Report Scope

    Attribute/Metric Details
    Market Size 2024 USD 4.89 Billion
    Market Size 2035 14.70 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR) 10.52% (2025 - 2035)
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Drug Treatment, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), AstraZeneca (U.S)
    Key Market Opportunities Dental Health Care Products
    Key Market Dynamics Rising incidence of periodontal disease
    Market Size 2025 5.40 (Value (USD Billion))

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    How much is the Halitosis Treatment market?

    The Halitosis Treatment market size was valued at USD 4.37 Billion in 2023.

    What is the growth rate of the Halitosis Treatment market?

    The market is projected to grow at a CAGR of 10.52% during the forecast period, 2024-2032.

    Which region held the largest market share in the Halitosis Treatment market?

    North America had the largest share in the market

    Who are the key players in the Halitosis Treatment market?

    The key players in the market are Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S),

    Which type led the Halitosis Treatment market?

    The Liver dominated the market in 2023.

    Which Drug Treatment had the largest market share in the Halitosis Treatment market?

    The antacids had the largest share in the market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials